MBIO 润色咨询

mBio

出版年份：2010 年文章数：5460 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：4.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2020-03-12 Biomed2015

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。

    @180****3363

    一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。

    8

    展开8条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2019-05-15 1801ed321dm

    一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2021-09-07 ms6000000383925720

    2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2018-12-26 1581fea663m

    投了5天 直接accept 惊呆 都没有修改

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2019-03-21 ms2798897682501839

    投稿了6天，还是with editor状态

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2022-05-13 ms7000000308199462

    偏重的研究方向：病毒;微生物
    经验分享：投稿14天，还是在编辑手里，太坑了

    13

    展开13条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2024-04-13 ms7000000797363888 来自浙江省

    1

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2023-12-19 Descuenxk 来自德国

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：病毒学
    经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2023-05-17 ms5000000232706336 来自丹麦

    偏重的研究方向：微生物
    经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570974, encodeId=d80a5e097460, content=一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d212057776, createdName=1801ed321dm, createdTime=Wed May 15 00:00:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015370, encodeId=e22310153e024, content=2021年4月低under review，2021年6月初返回，修改重投，2021年8月初under review，已经31天，目前还在审稿子，不知道结果怎么样？其中一张图片还上传错了，担心中，希望有好结果吧，。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691b5597611, createdName=ms6000000383925720, createdTime=Tue Sep 07 14:53:26 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564886, encodeId=e51056488684, content=投了5天 直接accept 惊呆 都没有修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eedc2139870, createdName=1581fea663m, createdTime=Wed Dec 26 00:00:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850389, encodeId=591085038982, content=投稿了6天，还是with editor状态 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Mar 21 16:29:10 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219221, encodeId=c03612192215e, content=偏重的研究方向：病毒;微生物<br>经验分享：投稿14天，还是在编辑手里，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri May 13 00:12:21 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2020-12-22 wnj1738555_28787312

    审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0
    偏重的研究方向：医学;病毒
    经验分享：mbio的质量距离plos pathogens还是有差距的
    别听这个版上的无脑喷子的话
    去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS
    mbio好像一篇都没有

    0

共117条页码: 1/12页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分